MarketInOut Stock Screener Log In | Sign Up

Poolbeg Pharma Plc

LSE • Healthcare • Biotechnology • Quote as of 10/27/2026 16:29
Poolbeg Pharma Plc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization46.54 mln
Float586 mln
Earnings Date03/04/2027

Piotroski F-Score

2 / 9
Weak

Relative Strength

85 / 100
Strongly outperforming

ROE

-60.09
Deeply negative

ROA

-55.59
Deeply negative

Business Description

Poolbeg Pharma PLC is a London-based pharmaceutical company founded in 2021 that works to bring new treatments to patients with conditions that currently have few good options. The company is advancing several programs, including a therapy for serious immune reactions triggered by cancer treatment, an oral drug for obesity and diabetes, and an AI-driven effort to find new medicines for influenza and respiratory viruses.

Key Fundamentals

EPS-1.00
ROE-60.09
ROIC-233
ROA-55.59
EBITDA, mln-5.45
EV / EBITDA-9.47
EV / EBIT-9.35

Quote Details

Last 6.70
Change -0.2 (-2.9%)
Open 6.75
Volume 789,269
Turnover 5,288,102
Average Volume 1,035,595

Financial Ratios

Leverage Ratio1.07
Current Ratio12.44
Price / Book7.40
Price / Tangible Book7.40

Financial Strength

Piotroski F-Score 2 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.06% 97 / 100   
1 Month -8.34% 14 / 100   
2 Months 9.84% 88 / 100   
6 Months 58.02% 97 / 100   
1 Year 67.5% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog